Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
IRTC · against 253 other Healthcare companies of similar size
Ranked #242 of 254 · scores higher than 5% of peers · safety percentile 7
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)20 peers with a safety percentile of 0–9, including IRTC · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | IRTC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 249 reported | 3.91× | 0.24× | 3% | 33% | |
| BetaLower is better · 251 reported | 1.32 | 0.54 | 15% | 33% | |
| Current ratioHigher is better · 243 reported | 3.85× | 2.49× | 64% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 3.6B USD | 99 | ||
| 5 | 2.2B USD | 99 | 48 | |
| 238 | 4.7B USD | 9 | 42 | |
| 239 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 17.6B CNY (≈$2.5B) |
| 8 |
| 11 |
| 240 | 2.5B USD | 7 | 32 |
| 241 | 5.1B USD | 7 | 54 |
| 242 | 4.2B USD | 7 | 41 |
| 243 | 1.9B EUR (≈$2.1B) | 6 | 52 |
| 244 | 18.7B CNY (≈$2.6B) | 6 | 51 |
| 245 | 7.3B USD | 6 | 32 |
| 246 | 7.0B USD | 5 | 57 |